Effects Of Generic-Only Drug Coverage In A Medicare HMO
- 1 January 2004
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 23 (Suppl1) , W4-455
- https://doi.org/10.1377/hlthaff.w4.455
Abstract
Rising pharmacy costs and demand for prescription drug coverage for broader populations of seniors have resulted in the implementation of generic-only pharmacy benefits in Medicare health maintenance organizations (HMOs). The impact on cost and quality of care is unknown. We examined data for members of a California Medicare HMO whose coverage changed to a generic-only benefit and found that the change was associated with reduced health plan pharmacy cost, increased out-of-pocket pharmacy costs for members, increased overall hospital admissions, changed drug-use patterns, and a negative impact on quality metrics for certain conditions. These findings have important implications for future research and health policy decisions.Keywords
This publication has 8 references indexed in Scilit:
- Pharmacy Benefits and the Use of Drugs by the Chronically IllJAMA, 2004
- The New Antiepileptic DrugsJAMA, 2004
- Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjectsThe American Journal of Cardiology, 2004
- Nephropathy in DiabetesDiabetes Care, 2004
- Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsArchives of internal medicine (1960), 2003
- Management of Dyslipidemia in Children and Adolescents With DiabetesDiabetes Care, 2003
- Are The Benefits Of Newer Drugs Worth Their Cost? Evidence From The 1996 MEPSHealth Affairs, 2001
- Efficacy and Adverse Effects of Established and New Antiepileptic Drugs*Epilepsia, 1995